Press releases
Regulatory press release 2023-05-02
Xspray announces a rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch
Regulatory press release 2023-04-13
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2023-03-29
Xspray Pharma publishes its Annual Report 2022
Regulatory press release 2023-02-23
Xspray Pharma Partners with EVERSANA for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)
Regulatory press release 2023-02-15
Interim Report Fourth Quarter 2022
Regulatory press release 2022-11-09
Interim Report Third Quarter 2022
Regulatory press release 2022-10-31
Number of shares and votes in Xspray Pharma
Regulatory press release 2022-10-25
Xspray Pharma’s Nomination Committee for the Annual General Meeting 2023
Regulatory press release 2022-10-17
Xspray Pharma has carried out a directed share issue raising proceeds of MSEK 100
Regulatory press release 2022-08-05